GlassScriptPhysician profile
Mary M Hagerty
NPI 1942279195
$2,613.68
in general payments reported to CMS, 2019-2025
21 companies · $92.26 in 2025
The $92.26 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,845 · 2020: $119 · 2021: $232 · 2022: $191 · 2023: $46.42 · 2024: $88.32 · 2025: $92.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207 · Education: $19.69.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.31 |
| Education | $19.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $586.47 | 2019-2024 | Prolia, Evenity, Tavneos |
| Abbvie INC. | $569.19 | 2019-2022 | |
| Janssen Biotech, INC. | $466.27 | 2019-2025 | Tremfya, Simponi Aria |
| Radius Health, INC. | $156.94 | 2019-2020 | |
| Glaxosmithkline, LLC. | $129.25 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $86.15 | 2019 | |
| Genentech USA, INC. | $82.87 | 2019-2020 | |
| Pacira Therapeutics, INC. | $72.21 | 2019 | |
| Lilly USA, LLC | $67.87 | 2019-2024 | Taltz, Zepbound |
| Regeneron Healthcare Solutions, INC. | $61.19 | 2019 | |
| Mallinckrodt Enterprises LLC | $58.73 | 2019 | |
| Horizon Therapeutics Plc | $46.00 | 2021 | |
| Ucb, INC. | $40.41 | 2019 | |
| Novartis Pharmaceuticals Corporation | $39.00 | 2019 | |
| Pfizer INC. | $35.85 | 2019-2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aurinia Pharma U.S., INC. | $32.84 | 2023 | Lupkynis |
| Sobi, INC | $22.54 | 2019 | |
| Fresenius Kabi USA, LLC | $18.33 | 2024 | Idacio |
| Alexion Pharmaceuticals, INC. | $15.95 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.66 | 2019 | |
| Depuy Synthes Sales INC. | $11.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Hagerty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.